Jump to content

Aprindine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Boghog (talk | contribs) at 16:21, 18 October 2022 (templated cites). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Aprindine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • {3-[2,3-dihydro-1H-inden-2-yl(phenyl)amino]propyl}diethylamine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H30N2
Molar mass322.496 g·mol−1
3D model (JSmol)
  • c1cccc3c1CC(N(c2ccccc2)CCCN(CC)CC)C3
  • InChI=1S/C22H30N2/c1-3-23(4-2)15-10-16-24(21-13-6-5-7-14-21)22-17-19-11-8-9-12-20(19)18-22/h5-9,11-14,22H,3-4,10,15-18H2,1-2H3 checkY
  • Key:NZLBHDRPUJLHCE-UHFFFAOYSA-N checkY
  (verify)

Aprindine is a Class 1b antiarrhythmic agent.[1]

It has been since discovered that the quat salts of Aprindine are also claimed to have an antiarrhythmic activity.[2][3]

Synthesis

The modern method uses Indene as the starting material since this is more stable than 2-indanone.

Thieme Patent:[4] Improved technology for the First step:[5]

The condensation between 2-Indanone [615-13-4] (1) and aniline gives an "anil" type Schiff's base[6] (2). The reduction with sodium borohydride forms the corresponding aminoindane [33237-72-8] (3). Sodium hydride catalyzed alkylation with 3-diethylaminopropyl chloride [104-77-8] (4) completed the synthesis of Aprindine (5).

See also

References

  1. ^ WHOCC. "WHOCC - ATC/DDD Index". www.whocc.no. Retrieved 2018-03-01.
  2. ^ US 3917679, Molloy BB, Tuttle RR, issued 1975, assigned to Eli Lilly and Co 
  3. ^ US 4018897, Molloy BB, issued 1977, assigned to to Eli Lilly and Co 
  4. ^ US 3923813, Vanhoof PM, Clarebout PM, issued 1975, assigned to Christiaens Sa A. 
  5. ^ JPH 1045687, Sasaki T, et al., issued 1998, assigned to Nippon Steel Corp 
  6. ^ "N-(Indan-2-ylidene)aniline". PubChem. U.S. Library of Medicine.